C-Rad
C-RAD AB is a Swedish medical technology company developing surface-guided radiation therapy (SGRT) positioning and patient tracking solutions for cancer treatment. The company manufactures optical 3D tracking systems, including Catalyst and Sentinel, that monitor patient positioning and respiratory motion in real time during radiation therapy. Main revenue drivers comprise global commercial sales of SGRT positioning systems, hardware accessories, and recurring software license and maintenance support contracts. C-RAD serves hospital radiation oncology departments, cancer treatment centers, linear accelerator manufacturers, and clinical oncologists across Europe, North America, and Asia. The company holds a market-leading global position in surface-guided radiation therapy and real-time patient positioning technology. Headquartered in Uppsala, Sweden, C-RAD AB is listed on Nasdaq Stockholm.
2 of the funds FundTelligence covers report a position in C-Rad.
- Legal name
- C-Rad Ab
- Sector
- Health Care
- Country
- Sweden
- Funds holding it
- 2
Funds holding C-Rad
- Storebrand Sverige Småbolag Plus — Storebrand · 0.03 % (full portfolio disclosed, October 2026)
- Storebrand Sverige Plus — Storebrand · 0.01 % (full portfolio disclosed, October 2026)